The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis
Open Access
- 1 August 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Abstract
Systemic immune changes have been implicated in amyotrophic lateral sclerosis (ALS), but precise mechanisms and cellular targets remain unknown. Neuromuscular junction (NMJ) denervation is another major pathophysiological event in ALS, but it remains unclear whether immune system dysregulation contributes to this process. Here, we report leukocyte and macrophage infiltration in ALS patient-derived skeletal muscle biopsies. Immune cell infiltration was replicated across the hTDP-43, TDP-43A315T (male only) and TDP-43M337V mouse models, occurring from pre-symptomatic stages and targeted to NMJ-enriched muscle regions. Proteomic analysis implicated the CCL2-CCR2 axis as a driving factor. CCL2+ cells were enriched around NMJs in hTDP-43 mice, and in ALS patient skeletal muscle. Local treatment with CCL2-neutralising antibodies or normal IgG antibodies in hTDP-43 mice reduced leukocyte infiltration and ameliorated NMJ denervation. These results demonstrate that the CCL2-CCR2 axis drives immune cell infiltration targeting NMJs in ALS, identifying a potential avenue for therapeutic intervention to prevent NMJ denervation.Keywords
Funding Information
- MND Scotland (2021/MNDS/RP/8430GILL)
This publication has 46 references indexed in Scilit:
- CCL2 Knockdown Attenuates Inflammatory Response After Spinal Cord Injury Through the PI3K/Akt Signaling Pathway: Bioinformatics Analysis and Experimental ValidationMolecular Neurobiology, 2023
- Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment seriesBiomedicine & Pharmacotherapy, 2023
- Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosisEBioMedicine, 2022
- Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis ProgressionJAMA Neurology, 2017
- MHCI promotes developmental synapse elimination and aging-related synapse loss at the vertebrate neuromuscular junctionBrain, Behavior, and Immunity, 2016
- Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)Experimental Neurology, 2016
- Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosisMuscle & Nerve, 2005
- Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and manExperimental Neurology, 2004
- Intravenous immunoglobulin therapy in amyotrophic lateral sclerosisJournal of Neurology, 1996
- Effect of High-Dose Intravenous Immunoglobulin on Amyotrophic Lateral Sclerosis and Multifocal Motor NeuropathyArchives of Neurology, 1994